Shilpa Medicare (Small Cap - Next Multibagger) Share Target 2024, 2025 To 2039
|
Shilpa Medicare Limited |
|||
|
Price: ₹813.15 | ||
| 52 Week Low: ₹313.15 52 Week High: ₹959.50 |
|||
| Market Capital: 4,933.06 Crore (Smallcap) | |||
| Healthcare -> Drug Manufacturers - Specialty & Generic | |||
Show Table of Contents
Table of Contents
- 1: Approach 1: Technical Analysis Paired With Price Action
- 1.1: Shilpa Medicare Share Price Target For 2024
- 1.1.1: Shilpa Medicare Share Price Target Table For 2024
- 1.1.2: Short-Term Technical Outlook
- 1.2: Shilpa Medicare Share Price Target For 2025
- 1.2.1: Shilpa Medicare Share Price Target Table For 2025
- 1.2.2: Long-Term Technical Outlook
- 2: Approach 2: Machine Learning By Studying Historical Prices
- 2.1: Shilpa Medicare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
- 3: Shilpa Medicare Brief Company Overview
- 4: Shilpa Medicare Financial Performance
- 4.0.1: Is Shilpa Medicare A Good Buy For Long Term?
To predict the Shilpa Medicare's future market prices, we harnessed 2 dynamic approaches:
Approach 1: Technical Analysis Paired With Price Action
Approach 2: Machine Learning By Studying Historical Prices
Approach 1: Technical Analysis Paired With Price Action
Shilpa Medicare Share Price Target For 2024
The line chart displays the monthly closing prices of Shilpa Medicare with a black line. The green line shows three potential target prices for 2024, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Shilpa Medicare shares in 2024, see the table below.
Shilpa Medicare Share Price Target Table For 2024
| Level | Value | Analysis |
|---|---|---|
| 2024 Target 3 | 862.3 (+6.04%) | Price Action: 04 Dec 2024 Low |
| 2024 Target 2 | 852.92 (+4.89%) | Technical Indicator: MA50 |
| 2024 Target 1 | 844.3 (+3.83%) | Price Action: 20 Dec 2024 High |
| Current Price | 813.15 | Shilpa Medicare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 807.0 (-0.76%) | Price Action: 17 Dec 2024 Low |
| Stop Loss 2 | 797.9 (-1.88%) | Price Action: Aug 2024 High |
| Stop Loss 3 | 780.04 (-4.08%) | Price Action: 23 Oct 2024 Low |
Short-Term Technical Outlook
Current Technical Position: Shilpa Medicare is displaying bearish momentum trading below key moving averages.
Key Technical Level: The 50-day moving average at ₹852.65 serves as the nearest technical reference point.
Historical Returns: 3-month: -0.04% | 6-month: +42.76% | 1-year: +146.19%
Shilpa Medicare Share Price Target For 2025
The line chart displays the monthly closing prices of Shilpa Medicare with a black line. The green line shows three potential target prices for 2025, while the red line indicates three potential Stop Loss levels.
For detailed target and stop loss values for Shilpa Medicare shares in 2025, see the table below.
Shilpa Medicare Share Price Target Table For 2025
| Level | Value | Analysis |
|---|---|---|
| 2025 Target 3 | 1282.68 (+57.74%) | Fibonacci Extension Level 150.00% |
| 2025 Target 2 | 1249.81 (+53.69%) | Price Action: Chart |
| 2025 Target 1 | 1237.44 (+52.17%) | Fibonacci Extension Level 64.90% |
| Current Price | 813.15 | Shilpa Medicare's share price as of 20 Dec 2024 |
| Stop Loss 1 | 714.26 (-12.17%) | Price Action: May 2017 High |
| Stop Loss 2 | 698.3 (-14.13%) | Price Action: Jul 2017 High |
| Stop Loss 3 | 685.73 (-15.67%) | Price Action: Chart |
Long-Term Technical Outlook
52-Week Range Analysis: Shilpa Medicare is currently trading near its 52-week high of ₹959.5, showing strong yearly momentum.
Long-Term Trend Analysis: The stock is maintaining a bullish long-term trend, trading above both 150-day and 250-day moving averages.
Long-Term Performance: 1-year: +146.19% | 3-year: +52.40% | 5-year: +191.04%
Stay ahead of the market! Get instant alerts on crucial market breakouts. Don't miss out on key opportunities!
Your phone number will be HIDDEN to other users.
Approach 2: Machine Learning By Studying Historical Prices
Shilpa Medicare Share Price Target Chart and Table From 2024, 2025, 2026 to 2039
| Year | Target 1 | Target 1 YoY Chg % | Target 2 |
|---|---|---|---|
| Current Price | ₹813.15 | ||
| 2024 | ₹1,088.43 | +33.85% | ₹1,104.76 |
| 2025 | ₹1,733.71 | +59.29% | ₹1,759.72 |
| 2026 | ₹2,388.84 | +37.79% | ₹2,424.67 |
| 2027 | ₹3,247.52 | +35.95% | ₹3,296.23 |
| 2028 | ₹4,066.06 | +25.21% | ₹4,127.05 |
| 2029 | ₹4,679.87 | +15.10% | ₹4,750.07 |
| 2030 | ₹5,180.03 | +10.69% | ₹5,257.73 |
| 2031 | ₹5,786.60 | +11.71% | ₹5,944.61 |
| 2032 | ₹6,843.64 | +18.27% | ₹6,946.29 |
| 2033 | ₹7,752.22 | +13.28% | ₹7,868.50 |
| 2034 | ₹8,271.31 | +6.70% | ₹8,395.38 |
| 2035 | ₹8,626.35 | +4.29% | ₹8,767.88 |
| 2036 | ₹9,184.36 | +6.47% | ₹9,712.80 |
| 2037 | ₹10,439.77 | +13.67% | ₹10,596.37 |
| 2038 | ₹11,438.37 | +9.57% | ₹11,609.95 |
| 2039 | ₹10,969.01 | -4.10% | ₹11,338.80 |
Note: Target 1 and Target 2 represent price levels that the stock is most likely to achieve during the respective year, based on machine learning algorithms analyzing historical price patterns and market behavior. These predictions are generated through comprehensive analysis of the stock's historical data using advanced ML models.
Shilpa Medicare Brief Company Overview
Shilpa Medicare Limited: A Global Healthcare Leader Founded in 1987, Shilpa Medicare Limited has established itself as a prominent player in the pharmaceutical industry. The company's diverse product portfolio includes oncology and non-oncology APIs, new drug delivery...
systems, peptides/biotech products, and specialty chemicals. With operations spanning India, the United States, Europe, and other international markets, Shilpa Medicare has a global footprint. The company's commitment to quality and innovation is reflected in its contract manufacturing services for a variety of dosage forms. Shilpa Medicare's reputation in the industry is built on its high standards of manufacturing and adherence to regulatory compliance. The company's commitment to research and development ensures that it remains at the forefront of innovation in the healthcare sector.Shilpa Medicare Financial Performance
| Metric | Value | Description |
|---|---|---|
| Market Capital | 4,933.06 Crore | Market valuation of Shilpa Medicare's shares. |
| Revenue (TTM) | 1,124.75 Crore | Total revenue generated by Shilpa Medicare over the past twelve months. |
| Net Income (TTM) | -6,707,000.00 | Net Profit or Loss after all the expenses over the past twelve months. |
| Operating Margin | +13.69% | Income from operations as a percentage of revenue, before taxes and interest. |
| Profit Margin | -0.06% | Net income as a percentage of revenue, after all expenses. |
| Revenue Growth (Quarterly) |
+9.10% | Change in revenue compared to the previous quarter. |
| Earnings Growth (YOY Quarterly) |
+13.65% | Change in earnings compared to the same quarter last year. |
| Debt-to-Equity (D/E) Ratio |
48.76 | Company's total debt divided by total shareholder equity. |
| Total Debt | 865.43 Crore | Sum of Shilpa Medicare's current & long-term financial obligations. |
| Total Cash | 23.97 Crore | Total amount of liquid funds available to Shilpa Medicare. |
| Beta | 0.77 | Beta is less than 1 indicating that the Shilpa Medicare's price is less volatile than the market. |
Is Shilpa Medicare A Good Buy For Long Term?
Shilpa Medicare's recent financial data indicates mixed signals. While its past performance and revenue growth have been impressive, its negative net profit and high debt raise concerns. The low profit margin suggests operational inefficiencies. For long-term investment, investors may want to consider more financially stable companies with consistent profitability and lower debt levels.
Disclaimer: The information provided on this page is for educational purposes only and should not be considered as financial advice. Historical performance data and technical analysis cannot guarantee future results. Stock investments are subject to market risks. Please consult with a qualified financial advisor before making any investment decisions.
All stock data shown is sourced from publicly available information and while we strive for accuracy, we cannot guarantee the absolute accuracy of all figures. Users should verify critical information from official sources before making investment decisions.
